Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Christgen

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Cancer Medicine|October 31, 2014
High frequency of lobular breast cancer in distant metastases to the orbitMieke Raap, Wiebke Antonopoulos, Maximilian Dämmrich, et al.
Cancers|August 7, 2021
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of TumorsMatthias Christgen, Gábor Cserni, Giuseppe Floris, et al.
Stem Cells Translational Medicine|February 11, 2017
Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44<sup>+</sup> Gastric Cancer Stem CellsSamarpita Barat, Xi Chen, Khac Cuong Bui, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
The Journal of Pathology|May 1, 2018
CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancerStephan Bartels, Jana Lisa van Luttikhuizen, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine ResistanceSophie Mueller, Isabel Grote, Stephan Bartels, et al.
The Journal of Pathology. Clinical Research|April 23, 2026
Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapyAnnika Nasdala, Leonie D Kandt, Martin Radner, et al.
Oncotarget|October 8, 2016
Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysisMatthias Christgen, Jana L van Luttikhuizen, Mieke Raap, et al.
Human Pathology|April 27, 2024
Immunohistochemical marker profiles for the differentiation of collagenous spherulosis from adenoid cystic carcinoma of the breastHenriette L Warm, Leonie D Kandt, Nora Schaumann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinomaJason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Cancer Medicine|October 31, 2014
High frequency of lobular breast cancer in distant metastases to the orbitMieke Raap, Wiebke Antonopoulos, Maximilian Dämmrich, et al.
Cancers|August 7, 2021
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of TumorsMatthias Christgen, Gábor Cserni, Giuseppe Floris, et al.
Stem Cells Translational Medicine|February 11, 2017
Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44<sup>+</sup> Gastric Cancer Stem CellsSamarpita Barat, Xi Chen, Khac Cuong Bui, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
The Journal of Pathology|May 1, 2018
CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancerStephan Bartels, Jana Lisa van Luttikhuizen, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine ResistanceSophie Mueller, Isabel Grote, Stephan Bartels, et al.
The Journal of Pathology. Clinical Research|April 23, 2026
Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapyAnnika Nasdala, Leonie D Kandt, Martin Radner, et al.
Oncotarget|October 8, 2016
Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysisMatthias Christgen, Jana L van Luttikhuizen, Mieke Raap, et al.
Human Pathology|April 27, 2024
Immunohistochemical marker profiles for the differentiation of collagenous spherulosis from adenoid cystic carcinoma of the breastHenriette L Warm, Leonie D Kandt, Nora Schaumann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinomaJason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, et al.
Pageof 11